1. Zaniani, Najmeh Riahi, Oroujalian, Andisheh, Valipour, Ali, Peymani, Maryam. 2021. LAMTOR5 expression level is a biomarker for colorectal cancer and lncRNA LAMTOR5-AS1 predicting miRNA sponging effect. In Molecular biology reports, 48, 6093-6101. doi:10.1007/s11033-021-06623-3. https://pubmed.ncbi.nlm.nih.gov/34374893/
2. Fang, Runping, Xu, Feifei, Shi, Hui, Zhang, Weiying, Ye, Lihong. 2019. LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity. In Oncogene, 39, 2290-2304. doi:10.1038/s41388-019-1146-2. https://pubmed.ncbi.nlm.nih.gov/31836847/
3. Pu, Youguang, Tan, Yiao, Zang, Chunbao, Cai, Shanbao, Huang, Dabing. 2021. LAMTOR5-AS1 regulates chemotherapy-induced oxidative stress by controlling the expression level and transcriptional activity of NRF2 in osteosarcoma cells. In Cell death & disease, 12, 1125. doi:10.1038/s41419-021-04413-0. https://pubmed.ncbi.nlm.nih.gov/34862368/
4. Chen, Guojie, Wang, Kai, Li, Guoshu, Xiao, Yangyang, Chen, Bo. 2021. Long Noncoding RNA LAMTOR5-AS1 Interference Affects MicroRNA-506-3p/E2F6-Mediated Behavior of Non-Small Cell Lung Cancer Cells. In Oncology research, 28, 945-959. doi:10.3727/096504021X16328213967104. https://pubmed.ncbi.nlm.nih.gov/34588094/
5. Zhao, Lianfang, Tang, Yuqin, Yang, Jiayan, Zhang, Yongqiang, Chen, Jianhui. 2023. Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer. In Frontiers in molecular biosciences, 10, 1208132. doi:10.3389/fmolb.2023.1208132. https://pubmed.ncbi.nlm.nih.gov/37409345/